[Which monitoring and follow-up in organ dysfunctions during severe sepsis?].
Martin
C
C
Département d'anesthésie-réanimation, hôpital Nord, chemin des Bourrely, 13015 Marseille, France.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008991:Monitoring, Physiologic; D009102:Multiple Organ Failure / Q000209:etiology* / Q000517:prevention & control; D011486:Protein C / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000150:complications*; D012720:Severity of Illness Index
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated